166 related articles for article (PubMed ID: 32462003)
1. Immunologic and Clinical Failure of Antiretroviral Therapy in People Living with Human Immunodeficiency Virus within Two Years of Treatment.
Asgedom SW; Maru M; Berihun B; Gidey K; Niriayo YL; Atey TM
Biomed Res Int; 2020; 2020():5474103. PubMed ID: 32462003
[TBL] [Abstract][Full Text] [Related]
2. First line antiretroviral treatment failure and associated factors among people living with HIV in northwest Ethiopia.
Genet A; Mekonnen Z; Yizengaw E; Mekonnen D
Afr Health Sci; 2021 Mar; 21(1):263-272. PubMed ID: 34394306
[TBL] [Abstract][Full Text] [Related]
3. Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia.
Hailu GG; Wasihun AG
BMC Infect Dis; 2021 Jun; 21(1):561. PubMed ID: 34118891
[TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of treatment failure among children on first-line antiretroviral therapy in Amhara Region Referral Hospitals, northwest Ethiopia 2018: A retrospective study.
Yihun BA; Kibret GD; Leshargie CT
PLoS One; 2019; 14(5):e0215300. PubMed ID: 31042743
[TBL] [Abstract][Full Text] [Related]
5. Time to initial highly active antiretroviral therapy discontinuation and its predictors among HIV patients in Felege Hiwot comprehensive specialized hospital: a retrospective cohort study.
Amera TG; Bogale KA; Tefera YM
AIDS Res Ther; 2021 Dec; 18(1):93. PubMed ID: 34863200
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Treatment Failure among Adult Antiretroviral Treatment (ART) Clients in Bale Zone Hospitals, South Eastern Ethiopia.
Haile D; Takele A; Gashaw K; Demelash H; Nigatu D
PLoS One; 2016; 11(10):e0164299. PubMed ID: 27716827
[TBL] [Abstract][Full Text] [Related]
7. Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy.
Puthanakit T; Kerr S; Ananworanich J; Bunupuradah T; Boonrak P; Sirisanthana V
Pediatr Infect Dis J; 2009 Jun; 28(6):488-92. PubMed ID: 19504731
[TBL] [Abstract][Full Text] [Related]
8. Immunological recovery, failure and factors associated with CD-4 T-cells progression over time, among adolescents and adults living with HIV on Antiretroviral Therapy in Northern Ethiopia: A retrospective cross sectional study.
Desta AA; Wubayehu Woldearegay T; Berhe AA; Futwi N; Gebremedhn Gebru G; Godefay H
PLoS One; 2019; 14(12):e0226293. PubMed ID: 31830095
[TBL] [Abstract][Full Text] [Related]
9. Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort. Swiss HIV Cohort Study.
Erb P; Battegay M; Zimmerli W; Rickenbach M; Egger M
Arch Intern Med; 2000 Apr; 160(8):1134-40. PubMed ID: 10789606
[TBL] [Abstract][Full Text] [Related]
10. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral treatment failure and associated factors among HIV patients on the first-line antiretroviral therapy at Mizan-Tepi University teaching hospital, Southwest Ethiopia: A cross-sectional study.
Siraj J; Feyissa D; Mamo Y; Zewudie A; Regesa T; Ejeta F; Feyisa D; Hasen G; Mohammed T; Aferu T
Medicine (Baltimore); 2021 Dec; 100(51):e28357. PubMed ID: 34941151
[TBL] [Abstract][Full Text] [Related]
12. The Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014.
He L; Pan X; Dou Z; Huang P; Zhou X; Peng Z; Zheng J; Zhang J; Yang J; Xu Y; Jiang J; Chen L; Jiang J; Wang N
PLoS One; 2016; 11(2):e0148915. PubMed ID: 26900702
[TBL] [Abstract][Full Text] [Related]
13. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of anemia before and after initiation of highly active antiretroviral therapy among HIV positive patients in Northwest Ethiopia: a retrospective study.
Tesfaye Z; Enawgaw B
BMC Res Notes; 2014 Oct; 7():745. PubMed ID: 25335859
[TBL] [Abstract][Full Text] [Related]
15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia.
Ayele G; Tessema B; Amsalu A; Ferede G; Yismaw G
BMC Immunol; 2018 Dec; 19(1):37. PubMed ID: 30558580
[TBL] [Abstract][Full Text] [Related]
17. Clinical and immunologic outcome in patients with human immunodeficiency virus infection, according to virologic efficacy in the year after virus undetectability, during antiretroviral therapy.
Abgrall S; Duval X; Joly V; Descamps D; Matheron S; Costagliola D;
Clin Infect Dis; 2003 Dec; 37(11):1517-26. PubMed ID: 14614675
[TBL] [Abstract][Full Text] [Related]
18. Renal Function Impairment and Associated Factors among HAART Naïve and Experienced Adult HIV Positive Individuals in Southwest Ethiopia: A Comparative Cross Sectional Study.
Mekuria Y; Yilma D; Mekonnen Z; Kassa T; Gedefaw L
PLoS One; 2016; 11(8):e0161180. PubMed ID: 27537338
[TBL] [Abstract][Full Text] [Related]
19. Virological and immunological failure of HAART and associated risk factors among adults and adolescents in the Tigray region of Northern Ethiopia.
Hailu GG; Hagos DG; Hagos AK; Wasihun AG; Dejene TA
PLoS One; 2018; 13(5):e0196259. PubMed ID: 29715323
[TBL] [Abstract][Full Text] [Related]
20. Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value.
Oliveira R; Krauss M; Essama-Bibi S; Hofer C; Robert Harris D; Tiraboschi A; de Souza R; Marques H; Succi R; Abreu T; Della Negra M; Hazra R; Mofenson LM; Siberry GK;
Clin Infect Dis; 2010 Dec; 51(11):1325-33. PubMed ID: 21039218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
